FOX BIZ NEWS: Why MacroGenics Stock Rocketed 70.5% Higher in February
Why MacroGenics Stock Rocketed 70.5% Higher in February
Positive results for its breast cancer drug candidate lit a fire under this small-cap biotech.
Why MacroGenics Stock Rocketed 70.5% Higher in February
Positive results for its breast cancer drug candidate lit a fire under this small-cap biotech.
No comments:
Post a Comment